BR0209144A - Composição associadas ao fator de crescimento de fibroblasto humano - Google Patents

Composição associadas ao fator de crescimento de fibroblasto humano

Info

Publication number
BR0209144A
BR0209144A BR0209144-5A BR0209144A BR0209144A BR 0209144 A BR0209144 A BR 0209144A BR 0209144 A BR0209144 A BR 0209144A BR 0209144 A BR0209144 A BR 0209144A
Authority
BR
Brazil
Prior art keywords
growth factor
fibroblast growth
human fibroblast
composition associated
methods
Prior art date
Application number
BR0209144-5A
Other languages
English (en)
Inventor
Lydie Bougueleret
Amos Bairoch
Original Assignee
Geneprot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc filed Critical Geneprot Inc
Publication of BR0209144A publication Critical patent/BR0209144A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES ASSOCIADAS AO FATOR DE CRESCIMENTO DE FIBROBLASTO HUMANO". A presente invenção refere-se a um polipeptídeo de FGF23, métodos e composições para produzir esse peptídeo, e métodos para usar o polipeptídeo, e agonistas e antagonistas do mesmo para tratar distúrbios de destruição de fosfato.
BR0209144-5A 2001-04-26 2002-04-26 Composição associadas ao fator de crescimento de fibroblasto humano BR0209144A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28661401P 2001-04-26 2001-04-26
US28818701P 2001-05-01 2001-05-01
US29342001P 2001-05-24 2001-05-24
PCT/EP2002/004660 WO2002088358A2 (en) 2001-04-26 2002-04-26 Human fibroblast growth factor-related compositions

Publications (1)

Publication Number Publication Date
BR0209144A true BR0209144A (pt) 2004-06-08

Family

ID=27403632

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209144-5A BR0209144A (pt) 2001-04-26 2002-04-26 Composição associadas ao fator de crescimento de fibroblasto humano

Country Status (8)

Country Link
US (1) US20040171825A1 (pt)
EP (1) EP1381683A2 (pt)
JP (1) JP2004527253A (pt)
CN (1) CN1602355A (pt)
AU (1) AU2002302581A1 (pt)
BR (1) BR0209144A (pt)
CA (1) CA2443719A1 (pt)
WO (1) WO2002088358A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI224620B (en) * 2000-08-11 2004-12-01 Kirin Brewery Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same
EP1466925B1 (en) 2001-12-28 2009-09-02 Kyowa Hakko Kirin Co., Ltd. Antibodies against fibroblast growth factor 23
WO2005045044A2 (en) * 2003-11-07 2005-05-19 Novartis Ag Use of fibroblast growth factor fragments
US7883705B2 (en) * 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
US8420088B2 (en) * 2008-01-28 2013-04-16 Novartis Ag Methods and compositions using FGF23 fusion polypeptides
EA201791238A1 (ru) 2014-12-04 2018-02-28 Новартис Аг Способы и композиции, в которых используются варианты полипептидов klotho

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398603A1 (en) * 2000-02-15 2001-08-23 Amgen, Inc. Fibroblast growth factor-23 molecules and uses thereof
EP1261638A2 (en) * 2000-03-08 2002-12-04 Chiron Corporation Human fgf-23 gene and gene expression products
AU2001245535A1 (en) * 2000-03-08 2001-09-17 Chiron Corporation Human fgf-23 gene and gene expression products
KR20090036151A (ko) * 2000-07-19 2009-04-13 인디애나 유니버시티 리서치 앤드 테크놀로지 코포레이션 신규 섬유아세포 성장 인자 (fgf23) 및 그의 이용 방법

Also Published As

Publication number Publication date
WO2002088358A2 (en) 2002-11-07
WO2002088358A3 (en) 2003-07-24
CA2443719A1 (en) 2002-11-07
US20040171825A1 (en) 2004-09-02
AU2002302581A1 (en) 2002-11-11
JP2004527253A (ja) 2004-09-09
EP1381683A2 (en) 2004-01-21
CN1602355A (zh) 2005-03-30

Similar Documents

Publication Publication Date Title
RS51898B (sr) Specifični agensi koji vezuju humani angiopoetin-2
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
ATE538805T1 (de) Fgf-varianten und anwendungsverfahren dafür
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
ATE448686T1 (de) Actriib-fusionspolypeptide und verwendungen dafür
ATE380029T1 (de) Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke
BR0211888A (pt) Materiais e métodos para promoção de reparo de tecido nervoso
HK1077518A1 (en) Peptides that modulate nerve growth factor (ngf) activity, their compositions and use
BR0317896A (pt) Complexos de cristais de proteìna e polìmeros iÈnicos
MY132120A (en) Bone health compositions derived from milk.
DE69838143D1 (de) Antimikrobielle peptide
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
EP1978994A4 (en) BMP-7 VARIANTS COMPOSITIONS, METHODS AND USES
DE60142239D1 (de) DEN PHOSPHORSÄURE-METABOLISMUS, DEN KALZIUM-METABOLISMUS, VERKALKUNG UND DEN VITAMIN D-METABOLISMUS KONTROLLIERENDE POLYPEPTIDE SOWIE FüR DIESE KODIERENDE DNA-MOLEKÜLE
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
BR0209144A (pt) Composição associadas ao fator de crescimento de fibroblasto humano
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
BR0207039A (pt) Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
BR0212287A (pt) Proteìna de ligação caspase-8, sua preparação e uso
DE60036469D1 (de) 17867, eine menschliche aminopeptidase
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: GENOVA LTD. (BM)

Free format text: TRANSFERIDO DE: GENEPROT, INC.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.